Tresiba Injection, Solution
Pricing Report NDC 0169-2662-11

Current NADAC: $9.02082 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Tresiba (NDC 0169-2662-11) is $9.02082 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Novo Nordisk, this medication is distributed in a 1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.02082
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2019, the NADAC wholesale price for (NDC ) has moved within a range of $9.02082 to $32.65306 per ML. Over this 6 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.0208 - $32.6531
Market Volatility
261.97% Variance
Latest Trend
0.07%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $9.02082 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $9.02718 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $9.02431 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $9.02426 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $9.02498 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $9.02498 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $9.02498 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $32.44296 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $32.44489 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $32.46983 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $32.48997 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 20, 2025 $32.48084 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026